Germany & France | Sharing experience and vision!

14 février 2023

🧠 What is the future of neurorehabilitation? What are the main trends?

More patients + heavier affected + less clinical resources?

  • How can we improve the clinical pathway for patients in acute phase?
  • How to implement new technologies?
  • How to combine IVS3 and IVS4 with other therapies?
  • What could be the optimized organization? Arm lab & Gait lab?

Few days ago, we had the pleasure to welcome one of our first customers in Germany, Klinik und Rehabilitationszentrum Lippoldsberg.

This was a wonderful opportunity to share our visions with management, doctor and therapists.

💡 Our partners are an incredible source of inspiration to develop new approaches

And we are very proud to announce:
📣 Lippoldsberg is our first IVS4 customer in Germany 😀!

DESS_post_TN_Germany_France
DESS_post_IN1_Join_Us
DESS_post_IN1_Join_Us

Autres actualités

Ageing population is a challenge for healthcare systems

Ageing population is a challenge for healthcare systems

02 avril 2024

"Dessintey a pour cheval de course le vieillissement de la population, la pénurie de soignants et l'inactivité."(Source : Lyon Capitale) Ageing population is a challenge for healthcare systems.Furthermore, with current resources and organisations, it is becoming more...

lire plus
How to promote activity for elderly people?

How to promote activity for elderly people?

28 mars 2024

On Tuesday, Dessintey was in south of France 🇫🇷 to test SRT5 device with elderly people. Ageing population is a challenge for healthcare systems. Collectively, we need to find solutions to develop intensive and diversified care pathways.Dessintey is committed to...

lire plus
A first in Hainaut 🇧🇪 !

A first in Hainaut 🇧🇪 !

27 mars 2024

EpiCURA hospital has just equipped with Dessintey IVS3 (Intensive Visual Simulation) to helps its patients recover from stroke, SRPC, trauma, etc. For many patients, action planning is altered or non-existent. They lose awareness of their own body, but also the memory...

lire plus